Staff Theme: Targeting Tumour Cells
Search News
Professor Peter Szlosarek
14th August 2018
My main research interest is in exploring why ASS1 is aberrantly expressed in human cancers and how this knowledge may be exploited for anticancer therapy. I lead an active translational programme from bench to bedside of the arginine-depleting agent ADI-PEG20 in several hard-to-treat cancers.
Read more
Professor Jane Sosabowski
14th August 2018
My research focuses on the development of radiopharmaceuticals for imaging and therapy of cancer, and translating these to the clinic
Read more
Dr Kevin Rouault-Pierre
14th August 2018
My main research interests are in haematopoietic stem cells (HSCs) and leukemic initiating cells. I seek to understand how intrinsic and extrinsic signals are integrated by normal and malignant stem cells.
Read more
Dr John Riches
13th August 2018
My major research interest is understanding the metabolism of chronic lymphocytic leukaemia and lymphoma with the aim that this will underpin the development of the next generation of anti-metabolic drugs for these diseases.
Read more
Dr Paulo Ribeiro
13th August 2018
Our research group is interested in uncovering the molecular mechanisms regulating tissue growth, invasion and metastasis using the fruit fly Drosophila melanogaster as a genetically tractable model organism.
Read more
Professor Prabhakar Rajan
13th August 2018
My laboratory research explores alternative pre-mRNA splicing in prostate cancer (PCa) biology, and liquid biopsy-derived molecular biomarkers of treatment outcomes.
Read more